Blood glucose is clinically referred to as glycosylated hemoglobin, which is an item that needs to be checked regularly in diabetic patients and reflects the patient’s blood glucose level over the past 2-3 months, and is used more often in clinical practice and is more accurate in assessing blood glucose in patients with diabetes.
Glycated hemoglobin itself refers to glucose or sugar, which is catalytically reflected in hemoglobin, so testing glycated hemoglobin is a good indicator of the body’s blood glucose level, and the normal reference range is generally between 4% and 6%. The normal reference range is generally between 4% and 6%. For different regions, different test reagents and different hospitals, the test results may vary, so it is recommended to refer to the normal value of the tested hospital to determine the patient’s blood glucose level. Usually, in patients with glycated hemoglobin over 9%, they should be given insulin therapy in a timely manner and combined with blood glucose levels to jointly determine the level of blood glucose control to avoid emergency complications of diabetes, such as diabetic ketoacidosis, diabetic lactic acidosis, diabetic hyperosmolar coma, etc.
Monitoring glycated hemoglobin in diabetic patients also prevents diabetic complications such as retinopathy, peripheral vascular disease, nephropathy, hypertension, coronary artery disease, and more.